All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
More information on our cookie policy.
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Special reports
Artificial intelligence
Coronavirus
Diagnosing and tracking COVID-19
Drugs to Watch 2020
The next pandemic
Premium reports
BioWorld Financings Reports
Disease Forecast Reports
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 12, 2021
Home
» First phase I data presented for retifanlimab in patients with advanced solid tumors
First phase I data presented for retifanlimab in patients with advanced solid tumors
Nov. 16, 2020
No Comments
Article reprints
Source:
https://science.bioworld.com/ddn/article.do?id=174918
BioWorld Science
Related Articles
Rubius reports initial data from phase I/II study of RTX-240 in advanced solid tumors
